Not medical advice. Talk to your provider before using any peptide.
Full disclaimerPeptide Schedule Research TeamReviewed Apr 20269 Citations
Turns your vial size, BAC water, and dose into exact syringe units. Free, no signup.
Adjust vial, water, and dose — answer updates live
All three take the same units for the same dose. A smaller barrel just spreads it over more space.
on a U-100 syringe for a 100mcg dose
Add 2 mL BAC water to your 2 mg vial. Draw to 10.0 units on a U-100 syringe for a 100mcg dose. This vial will last 20 doses.
Copy link saves these numbers in the address. Anyone who opens it sees the same draw.
Never miss a dose — 100mcg daily, draw 10.0 units on U-100 syringe.
Tracking needs a free account, about 20 seconds
The calculator stays free without one
B7-33 is a biased RXFP1 agonist that halved infarct size in mouse cardiac models without the tumor-promoting cAMP signaling of native relaxin-2. All data is preclinical. The 6-minute serum half-life and zero human trials make this a research-only compound with promising but unconfirmed anti-fibrotic potential.
View side effects and safety warnings →
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 100mcg | Daily |
| Moderate | 250mcg | Daily |
| Aggressive | 500mcg | Daily |
Your first vial of B7-33 will likely be 2 mg. Add 2 mL of bacteriostatic water and you get 1 mg/mL (1000 mcg/mL). On a standard insulin syringe, 10 units equals 100 mcg (beginner dose) and 25 units equals 250 mcg (moderate dose). If you find a 5 mg vial, adding 2 mL gives you 2.5 mg/mL; then 100 mcg is 4 units and 250 mcg is 10 units. The thing most people miss with B7-33 is the dosing frequency. The 6-minute serum half-life means once-daily injection is almost certainly not enough. The published mouse protocol used 0.25 mg/kg twice daily, 12 hours apart. If you're only injecting once a day, you're probably not getting meaningful RXFP1 engagement throughout the day. Reconstituted B7-33 degrades fast at room temperature. Keep it at 2-8 degrees C and use it within 7-10 days. Prepare only the dose you need per session. The short half-life reflects real susceptibility to proteolysis; this isn't a peptide that tolerates sloppy storage. Request an HPLC/MS Certificate of Analysis from your vendor, 98% purity minimum. Degraded B7-33 looks identical to active peptide without mass spectrometry analysis.
Dosing based on Zero human data: dose based on preclinical research — 16 published references.View all sources →
Based on a 2mg vial, 2mL of bacteriostatic water, the beginner dose (100mcg), and a U-100 syringe. Change any input in the calculator and every line moves with it.
Cross-check your B7-33 reconstitution math with AI
Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →
Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.